Biophytis S.A.

Biophytis S.A.

BPTSY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$770.88K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Biophytis S.A.Biophytis S.A.0-178%--1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$770,875.00
Enterprise Value$7.34 Million
Earnings per Share$-2
Beta0.9
Outstanding Shares1,927,188

Return

Return on Equity177.83%ROE
Return on Assets-209.00%
Return on Invested Capital264.54%

Valuation & Multiples

P/E Ratio-0.02P/E Ratio
PEG-0.1PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.08Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-0.64
Enterprise Value to Net Income-1
Total Debt to Enterprise1.06
Debt to Equity-1Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 11, 2026
EPS Estimate
-$39.98
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
March 3, 2027
EPS Estimate
-$46.88
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Biophytis

2,020 employees
CEO: Stanislas Veillet

Biophytis S.A. is a clinical-stage biotechnology company dedicated to creating therapies designed to mitigate age-related degenerative processes and enhance functional well-being for patients. The company's scientific approach centers on...

Questions & Answers